483
J. Robert FlaminiJ. Robert Flamini – FDA 483, Mar 11, 2024
Record Details
An FDA inspection of J. Robert Flamini, a clinical investigator in Atlanta, GA, revealed a significant deviation from an investigational plan. Specifically, a pediatric subject in a study for partial-onset seizures was administered an incorrect dosage of the investigational product over an extended period. This indicates a failure to conduct the study in accordance with the approved protocol.
View Company Profile
ID · d766a527-9e35-4030-94b8-042b025ecf7b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.